• Explore /
  • Poster
  • / A comparison between next-generation sequencing and ASO-qPCR for minimal residual disease detection in multiple myeloma.

A comparison between next-generation sequencing and ASO-qPCR for minimal residual disease detection in multiple myeloma.

Abstract Poster

Authors

null

Hiroyuki Takamatsu

Kanazawa University, Graduate School of Medical Science, Kanazawa, Japan

Hiroyuki Takamatsu , Ryoichi Murata , Jianbiao Zheng , Martin Moorhead , Yasushi Terasaki , Takashi Yoshida , Malek Faham , Shinji Nakao

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lymphoma and Plasma Cell Disorders

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Multiple Myeloma

Citation

J Clin Oncol 31, 2013 (suppl; abstr 8601)

DOI

10.1200/jco.2013.31.15_suppl.8601

Abstract #

8601

Poster Bd #

55F

Abstract Disclosures

Similar Posters

First Author: Gun-Dong Lee

Poster

2023 ASCO Annual Meeting

Measurable residual disease (MRD) and clonal diversity for multiple myeloma treatment monitoring.

Measurable residual disease (MRD) and clonal diversity for multiple myeloma treatment monitoring.

First Author: Joaquin Martinez-Lopez

First Author: Jeries Kort

First Author: Ethan G. Thompson